News on your favorite shows, specials & more!

Andrew Lloyd Webber to be Vaccinated for the Oxford COVID-19 Trial

Lloyd Webber shared, - 'I’ll do anything to prove that theatres can re-open safely.'

By: Aug. 12, 2020
Get Access To Every Broadway Story

Unlock access to every one of the hundreds of articles published daily on BroadwayWorld by logging in with one click.




Existing user? Just click login.

Andrew Lloyd Webber has revealed via Twitter, that he is going to be vaccinated for the Oxford COVID-19 trial.

See the tweet below:

A COVID-19 vaccine, ChAdOx1, is being developed by the University of Oxford in the UK in collaboration with the biopharmaceutical company AstraZeneca. In May, the head scientist of the World Health Organization, Soumya Swaminathan, called ChAdOx1 the most advanced COVID-19 vaccine candidate.

Phases one and two of the clinical trial took place in April in the UK. Safety and Immune responses were checked in more than a thousand volunteers.

In April, the University of Oxford and AstraZeneca announced an agreement to produce a billion doses of the vaccine, and agreed to make the vaccine widely available.




Videos